Loading clinical trials...

Active Not RecruitingNCT05186857

Metabolome and Microbiome Impact on Acute GVHD in Recipients of Hematopoietic Transplant

Recent published data suggest that specific alterations in intestinal metabolome signature of hematopoietic stem cell transplant (allo-SCT) recipients might influence incidence and severity of acute g...

Lead sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla•9 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

FMT in Gut aGVHD Treated

NCT03148743 · Acute-graft-versus-host Disease

RECRUITINGPhase 1

A Phase Ib Clinical Study of AC-003 Capsules in Subjects With aGVHD.

NCT07070674 · Acute Graft-versus-Host Disease

RECRUITING

Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

NCT00001529 · Graft-Versus-Host Disease, Graft-versus-leukemia, and more

RECRUITINGNA

Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease

NCT06910969 · Bone Marrow Transplant Complications, Graft-versus-Host Disease

RECRUITINGPhase 2

Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy

NCT06660355 · Chronic Graft-versus-host Disease (cGVHD)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 16, 2026Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

Phase—

Enrollment88

Start dateJan 2023

Last updatedJan 16, 2026

Condition

Graft-versus-host Disease

Locations shown

Hospital Marqués de Valdecillas, Santander

Santander, Cantabria

Hospital Universitario Reina Sofía

Córdoba, Córdoba

Hospital Virgen de las Nieves de Granada

Granada, Granada

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 16, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions